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Different hiol-containing compounds, uch as diethyldithiocarbamate (DDC), glutathione, penicillamine, 
and dithioerythritol have been chosen to study their effect on ascorbate/Fe-ADP-induced lipid 
peroxidation, detected by low-level chemiluminescence andalkane production. In the concentration range 
used, these thiols exerted a temporary protection against lipid peroxidation by lengthening the induction 
period; after overcoming this induction period, no substantial inhibition of either chemiluminescence or 
alkane production was observed. DDC was effective in protecting against lipid peroxidation in the 
nanomolar range, whereas the group of other thiol-containing molecules operated in the millimolar ange. 
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1. INTRODUCTION 
Low-M, thiols have been shown to play a signifi- 
cant role in protecting membranes against oxida- 
tive damage. The molecular mechanism generally 
implies free radical interactions, which, within the 
frame of lipid peroxidation, may occur by either 
intercepting the formation of 02 free radicals at 
the initiation stage, or reacting with them at a later 
stage, mainly the propagation phase, or, in a 
secondary fashion, by acting as polar donors in the 
recovery of vitamin E after its reaction with free 
radicals. 
ma1 fractions against Fe-induced lipid peroxidation, 
presumably through a microsomally associated 
factor [5-71, which is dependent on vitamin E [8]. 
DDC has often been reported to inhibit completely 
the xenobiotic-induced accumulation of malondi- 
aldehyde as an indicator of lipid peroxidation [9]. 
Although free radical-thiol interactions do for- 
mally occur in model systems (see [l-4]), their 
physiological relevance for some thiols such as 
glutathione remains to be determined. However, 
glutathione [5-71 and other thiols [5] such as 
diethyldithiocarbamate (DDC), cysteamine, mer- 
captoethanol, etc. were found to protect microso- 
Although some reports emphasize the ‘inhibi- 
tory’ effect of some low-M, thiols on lipid peroxi- 
dation, it appears that they exert only a temporary 
protection, which in some cases is concentration 
dependent, up to the moment in which they are ex- 
hausted. We have assessed the effect of some thiols 
on ascorbate/Fe-ADP-induced lipid peroxidation 
of microsomal fractions by two sensitive techni- 
ques which reflect oxidative reactions, low-level 
chemiluminescence and alkane production. 
2. MATERIALS AND METHODS 
+ To whom correspondence should be addressed 
2.1. Biological materials and chemicals 
Rat liver microsomes were prepared as in [6]. 
DDC, D-(-)-penicillamine, and dithioerythritol 
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were obtained from Sigma (Munich), cyanidanol 
from Zyma GmbH (Munich), and GSH from 
Boehringer (Mannheim). 
2.2. Assays 
Low-level chemiluminescence [lo] and alkane 
(ethane and n-pentane) production [ 1 I] were meas- 
ured as previously described. Chemiluminescence 
was taken as an index of lipid peroxidation based 
on the correlations (r = 0.99) described between 
light emission and malondialdehyde accumulation 
[ 12,131; measurement of low-level chemilumines- 
cence allows continuous monitoring of peroxida- 
tion reactions [ 10,131. 
2.3. Experimental conditions 
Peroxidation of microsomal membranes was 
carried out by incubating the microsomal frac- 
tions (0.16-2.0 mg protein/ml) in 0.1 M potas- 
sium phosphate buffer (pH 7.4), containing 2 mM 
ADP/16pM FeS04; reactions were started upon 
addition of 0.5 mM ascorbate to the cuvette con- 
taining the microsomal suspension through thin 
polyethylene tubing (for low-level chemilumines- 
cence experiments). Alkane formation measure- 
ments were carried out in 43 ml flasks which were 
capped with a PVC septum impermeable to al- 
kanes. Thereafter, the reaction was started as 
described above. Head-space gas samples (5 ml) 
were withdrawn at different time points with gas- 
tight Hamilton syringes and rapidly replaced by 
the same volume of 02; values were corrected for 
alkane dilution [l 11. Both assays were performed 
at 37°C under constant oxygenation and stirring 
(chemiluminescence assays) or agitation (alkane 
formation measurements). 
3. RESULTS AND DISCUSSION 
Fig. 1 illustrates the experimental model we have 
chosen to study the effect of different thiol- 
containing compounds on low-level chemilumines- 
cence. The intensity of ascorbate/ADP-Fe-induced 
chemiluminescence (fig. 1) and alkane formation 
(fig.2) of rat liver microsomes starts to rise after 
overcoming a lag phase or induction period of 
about 6-10 min (TO); the presence of this lag phase 
has been reported in similar peroxidizing systems 
[7], except that malondialdehyde accumulation 
was used as a parameter to assess lipid peroxida- 
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Fig. 1. Effect of DDC on ascorbate/ADP-Fe-induced 
chemiluminescence of microsomal fractions. Assay con- 
ditions as described in section 2. Microsomal concentra- 
tion 0.34 mg protein/ml. Time course of the chemilumi- 
nescence r action in the absence and presence of DDC. 
70 and T, induction periods in the absence and presence 
of DDC, respectively. 
tion. This induction period is probably related to 
the occurrence of internal membrane antioxidants, 
such as vitamin E (0.16pg vitamin E/mg protein or 
0.7Opg vitamin E/mg PUFA [14]), and its dura- 
tion might be related to the content and free radi- 
0 
Fig.2. Effect of DDC on ascorbate/ADP-Fe-induced 
alkane production of microsomal fraction. Assay condi- 
tions as in fig.1. Microsomal concentration 0.91 mg 
protein/ml. Time course of n-pentane production in the 
absence (0) and presence (0) of 0.33 nmol DDC/mg 
protein. Inset: dependence of the inhibition of ethane 
and n-pentane production of DDC concentration. 
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cal quenching capacity of vitamin E. Brain homo- 
genates, with a low vitamin E : PUFA ratio, do not 
show this lag phase of Oz-induced chemilumines- 
cence [ 151, whereas liver homogenates [ 151 and iso- 
lated hepatocytes [131 have a 20-25 min induction 
period. 
In the presence of DDC, the duration of the in- 
duction period (7) is lengthened but the maximal 
chemiluminescence intensity (fig. 1) and alkane for- 
mation (fig.2), once the lag phase is overcome, is 
similar to that obtained in the absence of DDC. 
The chromatographic pattern of the alkanes is not 
changed in the presence of the thiol. 
The ~:TO ratio indicates the relative increase in 
duration of the lag phase in the presence of DDC 
and reflects the resistance of microsomes to lipid 
peroxidation. The 7: 70 ratio is exponentially related 
to the concentration of DDC relative to microsomal 
protein (fig.3). It is noteworthy that nanomolar 
concentrations of DDC are effective in giving 
temporary protection against ascorbate/ADP-Fe- 
induced lipid peroxidation. As shown in fig.3 this 
effect might involve a specific binding of DDC to 
microsomal components, since it is dependent on 
the concentration of microsomes in the assay 
system. DDC did not largely inhibit lipid peroxida- 
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Fig.3. Effect of different SH-containing molecules on 
~/TO ratio as estimated by low-level chemiluminescence. 
Assay conditions as in fig.1. Microsomal protein con- 
centration: 0.16-1.2mg protein/ml. 0.3 PM DDC (0). 
0.5 mM GSH (o), or penicillamine (A), or 
dithioerythritol (0). (+)-Cyanidanol-3 exerted a half- 
maximal inhibitory effect at a concentration of 
2-10 PM, (not shown). 
tion but rather exerted a temporary protection by 
lengthening the induction period. This can be 
easily assessed by monitoring continuously the oxi- 
dative reactions with the photon-counting techni- 
que; sampling at a certain given time, as done for 
malondialdehyde determination, could lead to the 
observation of low malondialdehyde values which 
just fall within the lag phase period and could be 
mistakenly attributed to an inhibition of lipid 
peroxidation [9]. The inset in fig.2 shows the rela- 
tionship between inhibition of alkane formation 
(ethane and n-pentane) and DDC concentration 
taken after 20min incubation. In the case where 
DDC concentration produces a 7 value longer than 
the incubation time, a small or negligible amount 
of alkanes would be detected. A DDC concentra- 
tion with a 7 value shorter than the incubation 
period would imply ‘no effect’ exerted by the thiol. 
A second group of thiols, including glutathione, 
D-(-)-penicillamine, and dithioerythritol, was tes- 
ted with the same experimental model of fig. 1. All 
of them, and at variance with DDC, were effective 
in the millimolar concentration range in lengthening 
the induction period, and their effect was not 
dependent on microsomal protein concentration in 
the assay. This is summarized for the different 
thiols in fig.3. At a concentration of 0.5 mM this 
second group of thiols exerts a lengthening of the 
lag phase expressed by a 7: 70 ratio of 1.8-2.1; in 
order to produce a similar 7: 70 ratio, 0.53 nmol 
DDC/mg protein is required. It is clear that there 
is a different mechanism between both groups. In 
addition, cyanidanol, a well-known free radical 
scavenger that does not contain thiol groups [16], 
displays a comparable effect to that of DDC in 
terms of concentration requirements; however, our 
previous results with 4-hydroxynonenal-enhanced 
chemiluminescence of isolated hepatocytes [ 171 
and with the model system reported here show that 
cyanidanol does not exert a temporary protection 
by lengthening the induction period, but rather 
inhibits irreversibly the development of chemilumi- 
nescence. Half-maximal inhibition is obtained with 
about 2-10rM cyanidanol (not shown), in agree- 
ment with a previous report on isolated hepato- 
cytes [17]. 
DDC has been shown to be involved in (a) in- 
hibition of microsomal monooxygenase activity 
[18]; this effect was used to explain the antihepato- 
toxic properties of DDC against xenobiotic-induced 
373 
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liver injury [9]; (b) inactivation of superoxide 
dismutase, probably through the formation of a 
copper-chelating product devoid of dismutating 
activity [19,20], at variance with the Oi--dismu- 
tating activity exhibited by Cu-penicillamine com- 
plexes [20]; (c) as an antidote for acute cadmium 
intoxication [21]; (d) as an inhibitor of ethanol 
metabolism and some aldehyde metabolizing en- 
zymes (see [l]). A common mechanism for these 
diverse effects is difficult to envisage at the present 
stage. Of the possibilities listed above, only the in- 
hibition of microsomal monooxygenase appears to 
apply relative to this study. In our model system 
(non-enzymatically induced peroxidation moni- 
tored by chemiluminescence), however, (i) no 
NADPH is present, which is a requirement to 
observe the inhibition of the hydroxylating activity 
of cytochrome P-450, and (ii) the concentration of 
DDC required to observe such an inhibition is 
lOOO-fold higher than that used here [18]. 
It seems, therefore, that the effect of DDC here 
observed at nanomolar concentrations relies on a 
free radical quenching capacity of the compound 
rather than on an influence on microsomal meta- 
bolic processes. The higher efficiency of DDC with 
regard to the other group of different thiols might 
rely on the hydrophobicity of the former against 
the hydrophilic nature of the latter. This could sug- 
gest a membrane-related effect of DDC, thus 
protecting the target more effectively against 02 
radicals formed during the ascorbate/ADP-Fe- 
induced chemiluminescence. 
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